ZYDUS LIFESCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 984.90 INR | -1.52% |
|
-1.59% | +1.36% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceuticals | 125B | 133B | 133B | 150B | 172B | |||||
Total Assets | 181B | 182B | 221B | 199B | 231B | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | 16.94B | 22.46B | 24.19B | 28.93B | 45.57B | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Pharmaceutical Products | ||||||||||
Consumer Products | 17.67B | 18.41B | 19.79B | 22.45B | 23.12B | |||||
Total Assets | 55.9B | 56.66B | 56.92B | 58.33B | 61.46B | |||||
EBT | 1.66B | 2.44B | 3.06B | 3.01B | 2.66B |
Geographical Revenue Distribution History
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 63.04B | 65.44B | 59.49B | 74.87B | 87.75B | |||||
Total Assets | 13.44B | 12.03B | 8.97B | 3.56B | 3.92B | |||||
CAPEX | - | - | - | - | - | |||||
India | 64.42B | 64.62B | 72.53B | 76.4B | 80.15B | |||||
Total Assets | 111B | 112B | 115B | 118B | 139B | |||||
CAPEX | - | - | - | - | - | |||||
Others | 15.07B | 20.96B | 20.63B | 21.11B | 27.57B | |||||
Total Assets | 4.97B | 4.8B | 4.94B | 5.16B | 4.86B | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- Financials Zydus Lifesciences Limited
- Business Segments